Your browser doesn't support javascript.
loading
Developing Lyophilized Formulations for Protein Biopharmaceuticals Containing Salt that Produce Placebos of Corresponding Appearance.
Davagnino, Juan; Gabrielson, John P.
Afiliação
  • Davagnino J; KBI Biopharma, Inc. 1 1101 Hamlin Rd, Durham, NC 27704. Electronic address: juan@davagnino.com.
  • Gabrielson JP; KBI Biopharma, Inc 1450 Infinite Dr, Louisville, CO 80027.
J Pharm Sci ; 111(10): 2930-2937, 2022 10.
Article em En | MEDLINE | ID: mdl-35777485
ABSTRACT
Obtaining an elegant finished pharmaceutical product remains a problem when salt concentration is high, protein concentration is low, and particularly when both conditions are combined. We propose a simple approach to develop a robust lyophilized formulation in the presence of salt and at low protein concentration. We combine this with a commercially viable lyophilization cycle that can serve as a starting point for many protein-based pharmaceutical products. In this manner the formulator scientist, even with little experience, can develop a robust and visually acceptable lyophilized product. In addition, this platform allows the production of placebo vials with no visual differences compared to the active product.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article